doi:10.3969/j.issn.1673-8640.2020.12.018

Abstract

CLC Number:

R446.1

References 15

[1]	WU L,ZOU S,WANG C,et al.Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in Chinese Han population from Chaoshan region in South China[J]. BMC Cardiovasc Disord,2019,19(1):125.
[2]	MOOSAZADEH M,MALEKI I,ALIZADEH-NAVAEI R,et al.Normal values of neutrophil-to-lymphocyte ratio,lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio among Iranian population:results of Tabari cohort[J]. Caspian J Intern Med,2019,10(3):320-325.
[3]	QU J,YUAN H Y,HUANG Y,et al.Evaluation of neutrophil-lymphocyte ratio in predicting bloodstream infection[J]. Biomark Med,2019,13(15):1255-1261.
[4]	KAPLAN M,ATES I,OZTAS E,et al.A new marker to determine prognosis of acute pancreatitis:PLR and NLR combination[J]. J Med Biochem,2018,37(1):21-30.
[5]	WU Y,CHEN Y,YANG X,et al.Neutrophil-to-lymphocyte ratio(NLR) and platelet-to-lymphocyte ratio(PLR) were associated with disease activity in patients with systemic lupus erythematosus[J]. Int Immunopharmacol,2016,36:94-99.
[6]	YAO C,LIU X,TANG Z.Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD[J]. Int J Chron Obstruct Pulmon Dis,2017,12:2285-2290.
[7]	XIA W K,LIU Z L,SHEN D,et al.Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma[J]. World J Surg Oncol,2016,14:127.
[8]	LALOSEVIC M S,MARKOVIC A P,STANKOVIC S,et al.Combined diagnostic efficacy of neutrophil-to-lymphocyte ratio(NLR),platelet-to-lymphocyte ratio(PLR),and mean platelet volume(MPV) as biomarkers of systemic inflammation in the diagnosis of colorectal cancer[J]. Dis Markers,2019,2019:6036979.
[9]	PRABAWA L P Y,BHARGAH A,LIWANG F,et al. Pretreatment neutrophil-to-lymphocyte ratio(NLR) and platelet-to-lymphocyte ratio(PLR) as a predictive value of hematological markers in cervical cancer[J]. Asian Pac J Cancer Prev,2019,20(3):863-868.
[10]	SUNER A,CARR B I,AKKIZ H,et al. Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics[J]. J Transl Sci,2019,5(3):10.15761/JTS.1000260
[11]	CHOI W J,CLEGHORN M C,JIANG H,et al.Preoperative neutrophil-to-lymphocyte ratio is a better prognostic serum biomarker than platelet-to-lymphocyte ratio in patients undergoing resection for nonmetastatic colorectal cancer[J]. Ann Surg Oncol,2015,22(Suppl 3):S603-S613.
[12]	HU H,YAO X,XIE X,et al.Prognostic value of preoperative NLR,dNLR,PLR and CRP in surgical renal cell carcinoma patients[J]. World J Urol,2017,35(2):261-270.
[13]	ERDAL E,NANIR M.Platelet-to-lymphocyte ratio(PLR) and plateletcrit(PCT) in young patients with morbid obesity[J]. Rev Assoc Med Bras(1992),2019,65(9):1182-1187.
[14]	KAPLAN M,ATES I,YUKSEL M,et al.The role of the PLR-NLR combination in the prediction of the presence of Helicobacter pylori and its associated complications[J]. Saudi J Gastroenterol,2018,24(5):294-300.
[15]	BINGHAM J,HASSEBROCK J,CHRISTENSEN A,et al.Screening for periprosthetic joint infections with ESR and CRP:the ideal cutoffs[J]. J Arthroplasty,2020,35(5):1351-1354.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 15

Related Articles 15

Recommended Articles

Metrics

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.